Literature DB >> 6247107

Coxsackie B virus antibody responses in juvenile-onset diabetes mellitus.

C G Ray, J P Palmer, J R Crossley, R H Williams.   

Abstract

A prospective serological study of patients with recently diagnosed juvenile-onset diabetes mellitus was carried out to determine neutralizing antibody responses to Coxsackie B viruses. The sera were tested with and without staphylococcal protein A absorption, to selectively ascertain whether specific IgM or IgG antibody predominated. Of eleven patients studied, ten had reciprocal antibody titres of sixteen or greater to at least one serotype. Three patients showed no reduction in titre in at least one serum sample after protein A absorption, suggesting a predominant IgM-specific primary response to a recent infection by a Coxsackie B virus. The findings support the possibility that at least some cases of juvenile-onset diabetes mellitus are closely related to Coxsackie B virus infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247107     DOI: 10.1111/j.1365-2265.1980.tb02723.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype.

Authors:  H E Larsson; K Lynch; B Lernmark; G Hansson; A Lernmark; S-A Ivarsson
Journal:  Diabetologia       Date:  2007-04-04       Impact factor: 10.122

Review 3.  Genetic background and environment contribute synergistically to the onset of autoimmune diseases.

Authors:  P Luppi; M R Rossiello; S Faas; M Trucco
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

4.  Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins.

Authors:  Benjamin J Andrick; Alexandra I Schwab; Brianna Cauley; Lauren A O'Donnell; Wilson S Meng
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

5.  Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.